Document:

Form of Subscription Agreement

 Exhibit 10.2 
 SUBSCRIPTION AGREEMENT 
 This subscription agreement (the “Subscription Agreement”)
is dated as of April 17, 2006, by and between the investor identified on the signature page hereto (the “Investor”) and SCOLR Pharma, Inc., a Delaware corporation (the “Company”), whereby the parties agree as
follows: 
 1. Subscription. 
 (a) Investor agrees to buy and the Company agrees to sell and issue to Investor such number of shares of common stock of the Company, $0.001 par value per share (the “Shares”), set forth on the
signature page hereto, for an aggregate purchase price set forth on the signature page hereto (the “Purchase Price”). 
 (b) The Shares have been registered on a Registration Statement on Form S-3, Registration Statement No. 333-129275, which registration statement (the “Registration Statement”) has been declared
effective by the Securities and Exchange Commission, has remained effective since such date and is effective on the date hereof. 
 (c) Settlement of the purchase and sale of the Shares shall occur via Investor’s brokerage account with Roth Capital Partners, LLC or Taglich Brothers, Inc., as the case may be (each a placement agent engaged by the Company in
connection with the sale and issuance of the Shares and referred to herein as a “Placement Agent”). 
 (d) IF
INVESTOR ELECTS SETTLEMENT VIA DELIVERY VERSUS PAYMENT (“DVP”), INVESTOR SHALL AFFIRM THE TRADE NO LATER THAN ONE (1) BUSINESS DAY AFTER THE TRADE DATE AS DETERMINED BY THE PLACEMENT AGENTS AND COMMUNICATED TO THE INVESTOR, AND
WHICH SHALL BE NO LATER THAN APRIL 21, 2006 (THE “TRADE DATE”), AND THE PURCHASE AND SALE OF THE SHARES SHALL BE SETTLED THREE (3) BUSINESS DAYS AFTER THE TRADE DATE (THE “CLOSING DATE”). 
 (e) IF INVESTOR ELECTS SETTLEMENT VIA A CASH ACCOUNT WITH A PLACEMENT AGENT, INVESTOR SHALL REMIT THE AMOUNT OF FUNDS EQUAL TO THE
AGGREGATE PURCHASE PRICE TO SUCH INVESTOR’S BROKERAGE ACCOUNT WITH THE APPLICABLE PLACEMENT AGENT AS SOON AS IS PRACTICABLE, AND IN ANY EVENT NO LATER THAN THE CLOSING DATE. 
 (f) Funds shall be delivered by the applicable Placement Agent on behalf of the Investor to the Company on the Closing Date unless
(i) the agreement between the Company and the Placement Agents (the “Placement Agency Agreement”) is terminated pursuant to the terms thereof or (ii) the conditions to closing in the Placement Agency Agreement have not
been satisfied. The Investor’s obligations are expressly not conditioned on the purchase by any or all other investors of the Shares that they have agreed to purchase from the Company. The Placement Agents shall have no rights in or to any of
the funds delivered by Investor pursuant to this Subscription Agreement. 
 (g) On the Closing Date, the Company shall deliver
the Shares to Investor’s brokerage account with the applicable Placement Agent, such Shares to be registered in such name or names as designated in writing by the Investor. The Shares shall be unlegended and free of any resale restrictions.

 (h) THE OFFERING AND SALE OF THE SHARES IS BEING MADE ON A “BEST EFFORTS” BASIS BY THE PLACEMENT AGENTS, AND NOT
ON AN UNDERWRITTEN 

 
BASIS. SETTLEMENT IS BEING MADE THROUGH BROKERAGE ACCOUNTS ESTABLISHED WITH THE PLACEMENT AGENTS FOR INVESTOR’S CONVENIENCE ONLY. 
 2. Company Representations and Warranties. The Company represents and warrants that: (a) it has full right, power and authority to enter into
this Subscription Agreement and to perform all of its obligations hereunder; (b) this Subscription Agreement has been duly authorized and executed by and constitutes a valid and binding agreement of the Company enforceable in accordance with
its terms; (c) the execution and delivery of this Subscription Agreement and the consummation of the transactions contemplated hereby do not conflict with or result in a breach of (i) the Company’s certificate of incorporation or
bylaws, or (ii) any material agreement to which the Company is a party or by which any of its property or assets is bound; (d) the Shares have been duly authorized for sale and issuance, and when issued and delivered by the Company against
payment therefor pursuant to this Subscription Agreement, will be validly issued, fully paid and nonassessable; (e) the Registration Statement and any post-effective amendment thereto, at the time it became effective, did not contain any untrue
statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading; (f) the prospectus contained in the Registration Statement, as amended or supplemented, did
not contain as of the effective date thereof, and as of the date hereof does not contain, any untrue statement of a material factor omit to state a material fact necessary in order to make the statements therein, in light of the circumstances under
which they were made, not misleading; and (g) all preemptive rights or rights of first refusal held by shareholders of the Company and applicable to the transactions contemplated hereby have been duly satisfied or waived in accordance with the
terms of the agreements between the Company and such shareholders conferring such rights. 
 3. Investor Representations, Warranties and
Acknowledgments. The Investor represents and warrants that: (a) it has full right, power and authority to enter into this Subscription Agreement and to perform all of its obligations hereunder; (b) this Subscription Agreement has been
duly authorized and executed by the Investor and constitutes a valid and binding agreement of the Investor enforceable against the Investor in accordance with its terms; (c) the execution and delivery of this Subscription Agreement and the
consummation of the transactions contemplated hereby do not conflict with or result in a breach of (i) the Investor’s certificate of incorporation or bylaws (or other governing documents), or (ii) any material agreement or any law or
regulation to which the Investor is a party or by which any of its property or assets is bound; and (d) prior to the execution hereof, Investor has received the Company’s preliminary prospectus supplement, and the accompanying base
prospectus dated November 17, 2005, relating to the Company’s sale of the Shares. 
 4. Miscellaneous. 
 (a) This Subscription Agreement constitutes the entire understanding and agreement between the parties with respect to its subject matter,
and there are no agreements or understandings with respect to the subject matter hereof which are not contained in this Subscription Agreement. This Subscription Agreement may be modified only in writing signed by the parties hereto. 
 (b) This Subscription Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the
same instrument and shall become effective when counterparts have been signed by each party and delivered to the other parties hereto, it being understood that all parties need not sign the same counterpart. Execution may be made by delivery by
facsimile. 
 (c) The provisions of this Subscription Agreement are severable and, in the event that any court or officials of
any regulatory agency of competent jurisdiction may determine that any one or more of the provisions or part of the provisions contained in this Subscription Agreement shall, for any reason, be held to be invalid, illegal or unenforceable in any
respect, such invalidity, illegality or 

  

 2 

 
unenforceability shall not affect any other provision or part of a provision of this Subscription Agreement and this Subscription Agreement shall be reformed
and construed as if such invalid or illegal or unenforceable provision, or part of such provision, had never been contained herein, so that such provisions would be valid, legal and enforceable to the maximum extent possible, so long as such
construction does not materially adversely effect the economic rights of either party hereto. 
 (d) All communications
hereunder, except as may be otherwise specifically provided herein, shall be in writing and shall be mailed, hand delivered, sent by a recognized overnight courier service such as Federal Express, or sent via facsimile or electronic mail, to the
party to whom it is addressed at the following addresses or such other address as such party may advise the other in writing: 
 To the Company: as set forth on the signature page hereto. 
 To the Investor: as set forth on the signature page
hereto. 
 All notices hereunder shall be effective upon receipt by the party to which it is addressed. 
 (e) This Subscription Agreement shall be governed by and interpreted in accordance with the laws of the State of Washington for contracts
to be wholly performed in such state and without giving effect to the principles thereof regarding the conflict of laws. To the extent determined by such court, the prevailing party shall reimburse the other party for any reasonable legal fees and
disbursements incurred in enforcement of, or protection of any of its rights under this Subscription Agreement. 
 [Signature page follows]

  

 3 

 If the foregoing correctly sets forth our agreement, please confirm this by signing and returning to us
the duplicate copy of this Subscription Agreement. 
  

									
		 		 	SCOLR PHARMA, INC.
					
		 		 		 	 By:
	 	  
		 		 		 		 	 Daniel Wilds, President and

		 		 		 		 	 Chief Executive Officer

  

									
	Number of Shares: _________________________________	 		 		 	
				
	Purchase Price Per Share: ___________________________	 		 		 	Address for Notice to the Company:
				
	Aggregate Purchase Price: ___________________________	 		 		 	 SCOLR Pharma, Inc.
 3625 132nd Avenue SE, Suite
400

	  
 INVESTOR:
______________________________________
	 		 		 	 Bellevue, Washington 98006
 Facsimile:
(425) 373-0181
 Attention: Chief Financial Officer

					
	 By:
	 	  	 		 		 	
		 	Name:	 		 		 	
		 	Title:	 		 		 	

  

									
	Address for Notice to Investor:	 		 	
			
	  	 		 	
			
	  	 		 	
				
	Facsimile: _________________________________________	 		 		 	
				
	 Email: ____________________________________________
	 		 		 	
				
	 Attention: _________________________________________
	 		 		 	

 [SIGNATURE PAGE TO SCOLR PHARMA, INC. SUBSCRIPTION AGREEMENT]Form of Common Stock Certificate

			
		 	Exhibit 4.3
	Number * *	 	Shares * *

  

					
	[Graphic omitted]	 	 [Graphic omitted]
  
 STRATEGIC HOTELS & RESORTS, INC.
	 	[Graphic omitted]
			
	 THIS CERTIFICATE IS
 TRANSFERABLE IN THE CITIES
OF
 CHICAGO, IL AND NEW YORK, NY
	 	 STRATEGIC HOTELS & RESORTS, INC.
 A CORPORATION FORMED UNDER THE LAWS OF THE STATE OF MARYLAND
	 	 SEE REVERSE FOR IMPORTANT NOTICE ON TRANSFER RESTRICTIONS AND OTHER INFORMATION
 CUSIP 86272T 10 6

 THIS CERTIFIES THAT 
  

					
	 [                                   ]
	  		  	
			
	 is the record holder of
	  	[                                      
                                        
         ]	  	

  
 FULLY PAID AND NONASSESSABLE
SHARES OF COMMON STOCK, $.01 PAR VALUE PER SHARE, OF 
 STRATEGIC HOTELS & RESORTS, INC. 
 (the “Corporation”), transferable on the books of the Corporation by the holder hereof in person or by its duly authorized attorney upon surrender of this
certificate properly endorsed. This certificate and the shares represented hereby are issued and shall be subject to all of the provisions of the charter of the Corporation and the Bylaws of the Corporation and any amendments thereto. This
Certificate is not valid unless countersigned by the Transfer Agent and Registrar. 
 WITNESS the facsimile seal of the Corporation and the
facsimile signatures of its duly authorized officers. 
 Dated: 
  

					
	  	 	                [Graphic omitted]                	  	  
	SECRETARY	 		  	CHIEF EXECUTIVE OFFICER

  
 AMERICAN BANK NOTE COMPANY

 Countersigned and Registered: 
 LASALLE BANK NATIONAL ASSOCIATION 
 Transfer Agent and Registrar 
  
  

			
	By: 	 	  
		 	Authorized Signature

 IMPORTANT NOTICE 
 The Corporation will furnish to any stockholder, on request and without charge, a full statement of the information required by
Section 2–211(b) of the Corporations and Associations Article of the Annotated Code of Maryland with respect to the designations and any preferences, conversion and other rights, voting powers, restrictions, limitations as to dividends and
other distributions, qualifications, and terms and conditions of redemption of the stock of each class which the Corporation has authority to issue and, if the Corporation is authorized to issue any preferred or special class in series, (i) the
differences in the relative rights and preferences between the shares of each series to the extent set, and (ii) the authority of the Board of Directors to set such rights and preferences of subsequent series. The foregoing summary does not
purport to be complete and is subject to and qualified in its entirety by reference to the charter of the Corporation, a copy of which will be sent without charge to each stockholder who so requests. Such request must be made to the Secretary of the
Corporation at its principal office or to the Transfer Agent. 
 The shares represented by this certificate are subject to restrictions on
Beneficial and Constructive Ownership and Transfer for the purpose, among others, of the Corporation’s maintenance of its status as a Real Estate Investment Trust under the Internal Revenue Code of 1986, as amended (the “Code”).
Subject to certain further restrictions and except as expressly provided in the charter of the Corporation, (i) no individual may Beneficially or Constructively Own shares of the Corporation’s Common Stock in excess of 9.8 percent (in
value or number of shares) of the outstanding shares of Common Stock of the Corporation unless such individual is an Excepted Holder (in which case the Excepted Holder Limit shall be applicable); (ii) no individual may Beneficially or
Constructively Own shares of Capital Stock of the Corporation in excess of 9.8 percent of the value of the total outstanding shares of Common Stock of the Corporation, unless such individual is an Excepted Holder (in which case the Excepted Holder
Limit shall be applicable); (iii) no Person may Beneficially or Constructively Own Capital Stock that would result in the Corporation being “closely held” under Section 856(h) of the Code or otherwise cause the Corporation to
fail to qualify as a REIT; and (iv) no Person may Transfer shares of Capital Stock if such Transfer would result in the Capital Stock of the Corporation being owned by fewer than 100 Persons. Any Person who Beneficially or Constructively Owns
or attempts to Beneficially or Constructively Own shares of Capital Stock which causes or will cause a Person to Beneficially or Constructively Own shares of Capital Stock in excess or in violation of the above limitations must immediately notify
the Corporation. If any of the restrictions on transfer or ownership are violated, the shares of Capital Stock represented hereby will be automatically transferred to a Trustee of a Trust for the benefit of one or more Charitable Beneficiaries. In
addition, the Corporation may redeem shares upon the terms and conditions specified by the Board of Directors in its sole discretion if the Board of Directors determines that ownership or a Transfer or other event may violate the restrictions
described above. Furthermore, upon the occurrence of certain events, attempted Transfers in violation of the restrictions described above may be void ab initio. All capitalized terms in this legend have the meanings defined in the charter of
the Corporation, as the same may be amended from time to time, a copy of which, including the restrictions on transfer and ownership, will be furnished to each holder of Capital Stock of the Corporation on request and without charge. Requests for
such a copy may be directed to the Secretary of the Corporation at its Principal Office. 
  

	
	  

 KEEP THIS CERTIFICATE IN A SAFE PLACE. IF IT IS LOST, STOLEN, MUTILATED OR DESTROYED, THE CORPORATION
WILL REQUIRE A BOND OF INDEMNITY AS A CONDITION TO THE ISSUANCE OF A REPLACEMENT CERTIFICATE. 
 The following abbreviations, when used
in the inscription on the face of this certificate, shall be construed as though they were written out in full according to applicable laws or regulations: 
  

									
	 TEN COM –
 TEN ENT –
 JT TEN –
	  	as tenants in common
as tenants by the entireties
as joint tenants with right of survivorship and
not as tenants in common	  		  	UNIF GIFT MIN ACT –	 	__________ Custodian ___________
	  	  		  		 	        (Cust)                          (Minor)
	  	  		  		 	under Uniform Gifts to Minors Act
	  	  		  		 	______________________________
	  	  		  		 	(State)
	  	  		  	UNIF TRF MIN ACT –	 	_________ Custodian (until age ___)
	  	  		  		 	      (Cust)
	  	  		  		 	__________ under Uniform Transfers
		  		  		  		 	     (Minor)
		  		  		  		 	to Minors Act __________________
		  		  		  		 	                            (State)

 Additional abbreviations may also be used though not in the above list. 
  

 For Value Received,
____________________________________ hereby sell, assign and transfer unto 
 PLEASE INSERT SOCIAL SECURITY OR OTHER 
 IDENTIFYING NUMBER OF ASSIGNEE 
  
  

			
	(PLEASE PRINT OR TYPEWRITE NAME AND ADDRESS, INCLUDING ZIP CODE, OF ASSIGNEE)
	  	 	  
		
	  	 	  
		
	  	 	 Shares

	 of the Common Stock represented by the within certificate, and do hereby irrevocably constitute and appoint
	 	
		
	  	 	 Attorney

	 to transfer the said stock on the books of the within-named Corporation with full power of substitution in the
premises.
	 	

  
  

			
	 Dated
	 	  

  

			
	 X
	 	  
		 	NOTICE: THE SIGNATURE(S) TO THIS ASSIGNMENT MUST CORRESPOND WITH THE
NAME(S) AS WRITTEN UPON THE FACE OF THE CERTIFICATE IN EVERY PARTICULAR,
WITHOUT ALTERATION OR ENLARGEMENT OR ANY
CHANGE WHATEVER.

  

			
	 Signature(s) Guaranteed:
	 	  
		 	THE SIGNATURE(S) MUST BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE
GUARANTEE MEDALLION PROGRAM, PURSUANT TO S.E.C. 17Ad–15.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00102-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00102-of-00352.parquet"}]]